Literature DB >> 26358851

Contribution of M470V variant to cystic fibrosis: First study in CF and normal Tunisian population.

M Nefzi1, S Hadj Fredj1, N Tebib2, S Barsaoui3, K Boussetta3, H Siala1, T Messaoud4.   

Abstract

PURPOSE: Determining the frequency of M470V polymorphism in cystic fibrosis and healthy cohort in Tunisia to establish the contribution of M470V polymorphism in cystic fibrosis variable presentation and course. Additionally, studying the origin of cystic fibrosis transmembrane conductance regulator gene in Tunisian population and its evolution among populations worldwide. PATIENTS AND METHODS: The genotyping of M470V marker was realized by PCR-RFLP technique in 34 unrelated patients and 50 healthy subjects.
RESULTS: Statistical difference was found in the genotype and allelic distribution between CF and control groups. Exclusive association between F508del allele and M470 allele was noted.
CONCLUSION: This study has contributed to better understanding involvement of the M470V polymorphism in the CF clinical expression in the Tunisian population and has confirmed the utility of this marker in the study of the origin and evolution of the CFTR locus in the human history.
Copyright © 2015. Published by Elsevier SAS.

Entities:  

Keywords:  CFTR gene; F508del mutation; Gène CFTR; Haplotype; M470V polymorphism; Mutation F508del; Polymorphisme M470V; Population tunisienne; Tunisian population

Mesh:

Substances:

Year:  2015        PMID: 26358851     DOI: 10.1016/j.patbio.2015.07.004

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  1 in total

1.  Current Status of Genetic Diagnosis Laboratories and Frequency of Genetic Variants Associated with Cystic Fibrosis through a Newborn-Screening Program in Turkey.

Authors:  Sevcan Tug Bozdogan; Cem Mujde; Ibrahim Boga; Ozge Sonmezler; Abdullah Hanta; Cagla Rencuzogullari; Dilek Ozcan; Derya Ufuk Altintas; Atil Bisgin
Journal:  Genes (Basel)       Date:  2021-01-31       Impact factor: 4.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.